Original Research

Published on 03 Jun 2024

Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis

in Pharmacology of Anti-Cancer Drugs

Bing Lu
Jiawen Shi
Tong Cheng
Congshuo Wang
Manyu Xu
Pingping Sun
Xiaojing Zhang
Lei Yang
Peng Li
Han Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397656

1,004 views
1 citation

Original Research

Published on 31 May 2024

Integrated pan-cancer analysis reveals the immunological and prognostic potential of RBFOX2 in human tumors

in Pharmacology of Anti-Cancer Drugs

Fengxian Huang
Long Jin
Xinyue Zhang
Min Wang
Congya Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1302134

1,258 views
1 citation

Original Research

Published on 31 May 2024

Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients

in Pharmacology of Anti-Cancer Drugs

Jiangang Sun
Xiaojing Li
Qian Wang
Peng Chen
Longfei Zhao
Yongshun Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1349459

2,325 views
1 citation

Original Research

Published on 30 May 2024

IL4I1: a novel molecular biomarker represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer

in Pharmacology of Anti-Cancer Drugs

Xiangrong Peng
Chuan Liu
Li Zhang
Yin Chen
Lixin Mao
Shenglin Gao
Xiaokai Shi
Li Zuo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365683

1,699 views

Review

Published on 30 May 2024

Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r future

in Pharmacology of Anti-Cancer Drugs

Harriet Lampe
Laura Tam
Aaron R. Hansen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399802

2,342 views

Original Research

Published on 28 May 2024

Integrated transcriptomic and immunological profiling reveals new diagnostic and prognostic models for cutaneous melanoma

in Pharmacology of Anti-Cancer Drugs

Changchang Li
Nanhui Wu
Xiaoqiong Lin
Qiaochu Zhou
Mingyuan Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389550

1,148 views
1 citation

Original Research

Published on 27 May 2024

Efficacy and safety of anti-angiogenic drug monotherapy and combination therapy for ovarian cancer: a meta-analysis and trial sequential analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Yao Xie
Fei Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423891

930 views
1 citation

Correction

Published on 27 May 2024

Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth

in Pharmacology of Anti-Cancer Drugs

Uttara Saran
Balaji Chandrasekaran
Ashish Tyagi
Vaibhav Shukla
Amandeep Singh
Arun K. Sharma
Chendil Damodaran

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420266

549 views

Original Research

Published on 27 May 2024

The value of plasma omega-3 polyunsaturated fatty acids in predicting the response and prognosis of cervical squamous cell carcinoma patients to concurrent chemoradiotherapy

in Pharmacology of Anti-Cancer Drugs

Pengbin Ping
Juan Li
Xiaoying Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379508

1,176 views

Original Research

Published on 24 May 2024

Natural compound Alternol exerts a broad anti-cancer spectrum and a superior therapeutic safety index in vivo

in Pharmacology of Anti-Cancer Drugs

Chenchen He
Linlin Ma
Jeff Hirst
Fei Li
Hao Wu
Wang Liu
Jiang Zhao
Feng Xu
Andrew K. Godwin
Xiangwei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1409506

906 views

Brief Research Report

Published on 24 May 2024

Dorsomorphin attenuates ABCG2-mediated multidrug resistance in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Xiao-Peng Li
Liang-Qi Cao
Ze-Zhong Yu
Ke He
Peng-Bo Ding
Ji-Sheng Li
Yi-Yao Shan
Yu-Bin Su
Zhong-Min Yuan
Zhi Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1393693

1,063 views

Editorial

Published on 23 May 2024

Editorial: New progress in the treatment of bone and soft tissue tumors

in Pharmacology of Anti-Cancer Drugs

Duoyi Zhao
Jiachen Yu
Chengbin Ma
Xiaoyu Xu
Zhiyu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430844

552 views

Original Research

Published on 22 May 2024

L-arginine combination with 5-fluorouracil inhibit hepatocellular carcinoma cells through suppressing iNOS/NO/AKT-mediated glycolysis

in Pharmacology of Anti-Cancer Drugs

Yile Hu
Yihao Xing
Gaolu Fan
Huaxia Xie
Qingzan Zhao
Ling Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1391636

1,432 views
1 citation

Original Research

Published on 21 May 2024

Comparative efficacy of six programmed cell death Protein-1 inhibitors as first-line treatment for advanced non-small cell lung cancer: a multicenter retrospective cohort study

in Pharmacology of Anti-Cancer Drugs

Siyuan Chen
Tao Li
Wenyu Yang
Ting Wang
Yuhui Qin
Zhijuan Du
Yanan Li
Pengfei Cui
Yi Hu
Zhefeng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390872

1,069 views

Original Research

Published on 21 May 2024

Protein and metabolic profiles of tyrosine kinase inhibitors co-resistant liver cancer cells

in Pharmacology of Anti-Cancer Drugs

Zengbin Wang
Linqing Wu
Yu Zhou
Zhong Chen
Tao Zhang
Hong Wei
Zhihong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1394241

1,523 views

Editorial

Published on 20 May 2024

Editorial: Education in pharmacology of anti-cancer drugs: 2023

in Pharmacology of Anti-Cancer Drugs

João G. Costa
Olivier Feron
Ana Sofia Fernandes

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422847

794 views

Navigation group

Articles

Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis

Integrated pan-cancer analysis reveals the immunological and prognostic potential of RBFOX2 in human tumors

Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients

IL4I1: a novel molecular biomarker represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer

Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r future

Integrated transcriptomic and immunological profiling reveals new diagnostic and prognostic models for cutaneous melanoma

Efficacy and safety of anti-angiogenic drug monotherapy and combination therapy for ovarian cancer: a meta-analysis and trial sequential analysis of randomized controlled trials

Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth

The value of plasma omega-3 polyunsaturated fatty acids in predicting the response and prognosis of cervical squamous cell carcinoma patients to concurrent chemoradiotherapy

Natural compound Alternol exerts a broad anti-cancer spectrum and a superior therapeutic safety index in vivo

Dorsomorphin attenuates ABCG2-mediated multidrug resistance in colorectal cancer

Editorial: New progress in the treatment of bone and soft tissue tumors

L-arginine combination with 5-fluorouracil inhibit hepatocellular carcinoma cells through suppressing iNOS/NO/AKT-mediated glycolysis

Comparative efficacy of six programmed cell death Protein-1 inhibitors as first-line treatment for advanced non-small cell lung cancer: a multicenter retrospective cohort study

Protein and metabolic profiles of tyrosine kinase inhibitors co-resistant liver cancer cells

Editorial: Education in pharmacology of anti-cancer drugs: 2023